[1]Institute of Immunopharmacology and Immunotherapy;
School of Pharmaceutical Sciences;
Shandong University;
Jinan 250012;
China;
[2]Institute of Immunology;
School of Life Sciences;
University of Science and Technology of China;
Hefei 230061;
China;
[1]Institute of Immunopharmacology and Immunotherapy;
School of Pharmaceutical Sciences;
Shandong University;
Jinan 250012;
China;
Natural killer cell; Immunotherapy; Cancer; Clinical trial; Chimeric antigen receptor;